+1 (202) 780-33972024: Volume 8, Issue 3
Commentary P.1-2
Revealing the future: encouraging advancements in cancer clinical trials
Author(s): Stépn Urcun
DOI: 10.35841/aamor-8.3
Opinion Article P.1-2
The unsung heroes of cancer prevention are tumor suppressors.
Author(s): Govind Jhodia
DOI: 10.35841/aamor-8.5.232
Perspective P.1-2
Protectors without a voice: Comprehending the potential of tumor suppressor genes
Author(s): Kenneth Wber
DOI: 10.35841/aamor-8.3.233
Rapid Communication P.1-2
Precision medicine in practice: learnings from state-of-the-art clinical trials in oncology
Author(s): Thom Pisan
DOI: 10.35841/aamor-8.3.234
Short Communication P.1-2
An extensive review of patient-centric methods in cancer clinical trials
Author(s): Mchip Schip
DOI: 10.35841/aamor-8.3.235
Commentary P.1-2
Investigating the roles of tumor suppressor proteins as molecular gatekeepers
Author(s): Yurou Chu
DOI: 10.35841/aamor-8.3.236
Opinion Article P.1-2
Highlighting Recent Advances and Developments in Oncology Clinical Trials
Author(s): Dennis Smith
DOI: 10.35841/aamor-8.3.237
Perspective P.1-2
Tumor Suppressors: Uncovering Their Role as Guardians of Cellular Harmony
Author(s): Jewry Yoon
DOI: 10.35841/aamor-8.3.238
Research Article P.1-2
Deciphering the signaling pathways of tumor suppressors: Cracking the code
Author(s): Peiz Lin
DOI: 10.35841/aamor-8.3.239
Short Communication P.1-2
Prostate Cancer Biomarkers Are Strongly Supported Over Important Regulations.
Author(s): Nil Poole
DOI: 10.35841/aamor-8.3.240